Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group.

Alexander I SpiraMark D Stewart Suzanne F Jones Elaine ChangAnitra FieldingNicole RichieLaura S WoodMichael A ThompsonAbhilasha NairBrandon A MahalDavid E Gerber

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)

Tailoring the use of laboratory test requirements and testing intervals may increase the number and diversity of patients in clinical trials and provide clinical data that more closely represent the general practice populations.See related commentary by Giantonio, p. 2369.

Keyphrases

clinical trial
general practice
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
phase ii
prognostic factors
squamous cell carcinoma
randomized controlled trial
electronic health record
study protocol
clinical practice
squamous cell
artificial intelligence
data analysis